COR Initiate-Develop
Impact Outcomes-Based Learning

Continuous Subcutaneous Insulin Infusion (CSII) in T2 Diabetes INITIATE/ DEVELOP COURSES

DESCRIPTION

The T2 Center of Reference Develop courses are a 1.5 day program. Each course is organized once per year, taking place in Paris, by Prof. Yves Reznik. The program is conducted within a small group (10-15 participants only) in order to maximize learning outcome.

The starting point for each of these courses is the importance of the multi-disciplinary team approach in the treatment of your patients.  Not only will you be challenged in the optimal CSII use in T2 diabetes by the analysis of multiple case studies during small group work, the philosophy of whole integrated care approach is common to all of these leading host centers.  Psychological aspects of education come more and more to the forefront.

We will incorporate follow-up virtual classrooms to discuss progress that you’ve made back in your clinic.

AUDIENCE

We are looking for participants with experience in indicating and initiating pump therapy in T2 patients with the knowledge and understanding of the simple approach of the Getting2Goal protocol. 

PREREQUISITES

Attendees should be familiar with pump therapy and have a good understanding of treatment modalities in T2 and have an experience on initiating pump therapy in at least 5 patients.

Participants need to be familiar with the Clinical Evidence, particularly the OpT2mise study and the Getting2Goal protocol, and ideally complete the available e-learning modules at least a week before attending the session. Sending 1 patient case in to the faculty a minimum of 1 week before event.

 We are working on the new branding and new promotional materials.

 

OBJECTIVE LOCATION

Hyatt Regency Paris Etoile, Paris

FORMAT

Due to the convenient access, the course is held in Paris and run by Prof. Yves Reznik, the head of the Endocrinology Department, Caen University Hospital – Head Investigator of OpT2mise study, pioneer in pump therapy for T2 patients.